Lv1
22 积分 2024-06-11 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
4天前
已完结
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
4天前
已完结
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer
18天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
19天前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
20天前
已完结
Liver metastases
20天前
已完结
Defining and Modulating ‘BRCAness’
1个月前
已完结
BRCAness revisited
1个月前
已完结
An Overview of Clinical Development of Agents for Metastatic or Advanced Breast Cancer Without ERBB2 Amplification (HER2-Low)
1个月前
已完结
Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice
1个月前
已完结
皖公网安备34019202002308
